← Back to Clinical Trials
Recruiting NCT06254768
NCT06254768 Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT06254768 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of California, Los Angeles |
| Condition | Pediatric Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2023-01-17 |
| Primary Completion | 2024-03 |
Trial Parameters
Condition Pediatric Obesity
Sponsor University of California, Los Angeles
Study Type INTERVENTIONAL
Phase N/A
Enrollment 30
Sex ALL
Min Age 10 Years
Max Age 21 Years
Start Date 2023-01-17
Completion 2024-03
Interventions
Continuous glucose monitor
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.
Eligibility Criteria
Inclusion Criteria: * Age 10-21 years BMI \>95th percentile Exclusion Criteria: * Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity * Intellectual disability * Previous or planned bariatric surgery * Hemoglobin A1c \>6.5 % * Current use of medication that impacts weight
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology